NCT00310700View on ClinicalTrials.gov

Kinetics of B Cell Response in Infants Menjugate Vaccination

PHASE4CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Prevention of Meningococcal Infection

Interventions

BIOLOGICAL

Meningococcal C conjugate vaccine

Trial Locations (1)

OX3 7LJ

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY

NCT00310700 - Kinetics of B Cell Response in Infants Menjugate Vaccination | Biotech Hunter | Biotech Hunter